NCT05901714View on ClinicalTrials.gov

A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of Midazolam

PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

June 14, 2023

Primary Completion Date

April 11, 2024

Study Completion Date

April 11, 2024

Conditions
Healthy Participants
Interventions
DRUG

Afimetoran

Specified dose on specified days

DRUG

Phenytoin

Specified dose on specified days

DRUG

Midazolam

Specified dose on specified days

Trial Locations (1)

33136

Local Institution - 0001, Miami

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05901714 - A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of Midazolam | Biotech Hunter | Biotech Hunter